The Food and Drug Administration's Comprehensive, Multi-Year Nutrition Innovation Strategy; Public Meeting; Request for Comments, 30180-30182 [2018-13831]
Download as PDF
<![CDATA[
30180
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–13793 Filed 6–26–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Availability of Program Application
Instructions for Tribal MIPPA Program
Funds
daltland on DSKBBV9HB2PROD with NOTICES
Title: Medicare Beneficiary Outreach
and Assistance Program: Funding for
Title VI Native American Programs.
Announcement Type: Initial.
Funding Opportunity Number: HHS–
2018–ACL–MITRB–1802.
Statutory Authority: The statutory
authority for grants under this program
announcement is contained in
Subsection (a)(1)(B) of section 119 of the
Medicare Improvements for Patients and
Providers Act of 2008, as amended by
section 3306 of the Patient Protection
and Affordable Care Act, section 610 of
the American Taxpayer Relief Act of
2012, section 1110 of the Pathway for
SGR Reform Act of 2013, and section
110 of the Protecting Access to Medicare
Act of 2014, and section 208 of the
Medicare Access and CHIP
Reauthorization Act of 2015 (MACRA).
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.071.
Dates: The deadline date for the
submission of applications is 11:59PM
EST August 17, 2018.
I. Funding Opportunity Description
Section 110 of the Protecting Access
to Medicare Act of 2014 extended
funding for outreach and assistance for
low income programs under the
Medicare Improvements for Patients and
Providers Act (MIPPA). Older
Americans Act (OAA) Title VI Native
American Programs can fill an
important role in providing valuable
support to help eligible Native
American elders in accessing the Low
Income Subsidy program (LIS),
Medicare Savings Program (MSP),
Medicare Part D, Medicare prevention
benefits and screenings and in assisting
beneficiaries in applying for benefits.
The purpose of these MIPPA grants will
be to help inform eligible Native
American elders about these benefits.
The Administration for Community
Living (ACL) seeks certification from
OAA Title VI Native American
programs that they will use the funds to
VerDate Sep<11>2014
16:58 Jun 26, 2018
Jkt 244001
coordinate at least one community
announcement and at least one
community outreach event to inform
and assist eligible American Indian,
Alaska Native or Native Hawaiian elders
about the benefits available to them
through Medicare Part D, the Low
Income Subsidy, the Medicare Savings
Program or Medicare prevention
benefits and screenings and counsel
those who are eligible.
II. Award Information
ACL/AoA has a total budget of
$270,000 for the Tribes and will provide
a grant of at least $1,000 to each Older
Americans Act Title VI Native American
grantee. ACL reserves the right to adjust
funding levels subject to the number of
applications received and availability of
funds. ACL/AoA will award grants of at
least $1,000 to each Title VI Native
American grantee for a period of 12
months. The example of at least $1,000
per event is for illustrative purposes
only. All expenditures must be properly
documented and allowable per the
terms and conditions of the grant award.
The anticipated award date is on or
before September 30, 2018.
III. Eligibility Criteria and Other
Requirements
Only current Older Americans Act
Title VI Native American Program
grantees are eligible to apply for this
funding opportunity. Cost Sharing or
Matching is not required.
IV. Submission Information
The program instructions and onepage application template for this
funding opportunity are available at
www.grants.gov. At the website, search
for HHS–2018–ACL–MITRB–1802.
To receive consideration, signed
applications must be submitted by 11:59
p.m. Eastern time on August 17, 2018.
No applications will be accepted after
this date. Submit your signed
application via:
(1) Email to MIPPA.Grants@
acl.hhs.gov. Include the State, Name of
Tribe, and Title VI Part A Grant Number
and the words ‘‘MIPPA Application’’ in
the subject line; or
(2) Overnight mail (FedEx, UPS, or
USPS) to: Administration for
Community Living, Office of Grants
Management, 330 C Street SW, Suite
1136B, Washington, DC 20201;
Attention: Yi-Hsin Yan.
V. Agency Contacts
Direct inquiries regarding this funding
opportunity to U.S. Department of
Health and Human Services,
Administration for Community Living,
Administration on Aging, Washington,
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
DC 20201, attention: Cecelia Aldridge or
by calling (202) 795–7293 or by email
Cecelia.Aldridge@acl.hhs.gov.
Dated: June 20, 2018.
Mary Lazare,
Principal Deputy Administrator.
[FR Doc. 2018–13811 Filed 6–26–18; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–2381]
The Food and Drug Administration’s
Comprehensive, Multi-Year Nutrition
Innovation Strategy; Public Meeting;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA or we) is
announcing the following public
meeting entitled ‘‘FDA’s
Comprehensive, Multi-Year Nutrition
Innovation Strategy.’’ The purpose of
the public meeting is to give interested
persons an opportunity to discuss FDA’s
nutrition innovation strategy, including:
A standard icon or symbol for the claim
‘‘healthy’’; a more efficient review
strategy for evaluating qualified health
claims; statements or claims that could
facilitate innovation to promote
healthful eating patterns; approaches for
modernizing standards of identity;
possible changes that could make
ingredient information more consumer
friendly; and FDA’s educational
campaign for consumers about the
updated Nutrition Facts Label that
consumers will be seeing in the
marketplace.
DATES: The public meeting will be held
on July 26, 2018, from 8:30 a.m. until
5:30 p.m. Eastern Time. Submit either
electronic or written comments on this
public meeting by August 27, 2018. See
the SUPPLEMENTARY INFORMATION section
for registration date and information.
ADDRESSES: The public meeting will be
held at the Hilton Washington DC/
Rockville Hotel, 1750 Rockville Pike,
Rockville, MD 20852. For more
information on the hotel see https://
www3.hilton.com/en/hotels/maryland/
hilton-washington-dc-rockville-hoteland-executive-meeting-ctr-IADMRHF/
index.html.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
SUMMARY:
E:\FR\FM\27JNN1.SGM
27JNN1
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices
Electronic comments must be submitted
on or before August 27, 2018. The
https://www.regulations.gov electronic
filing system will accept comments
until midnight Eastern Time at the end
of August 27, 2018. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
daltland on DSKBBV9HB2PROD with NOTICES
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2018–N–2381 for ‘‘FDA’s
Comprehensive, Multi-Year Nutrition
Innovation Strategy.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
VerDate Sep<11>2014
16:58 Jun 26, 2018
Jkt 244001
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
For questions about registering for the
meeting or to register by phone: Melissa
Schroeder, SIDEM, 1775 Eye St, NW,
Suite 1150, Washington, DC 20006,
240–393–4496, EventSupport@
Sidemgroup.com.
For general questions about the
meeting or for special accommodations
due to a disability: Juanita Yates, Center
for Food Safety and Applied Nutrition
(HFS–009), Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–1731,
email: Juanita.yates@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
30181
I. Background
FDA plays a critical role in promoting
public health by, among other things,
ensuring that food labeling provides
consumers with reliable, evidence-based
information so that they can make
informed choices about the foods they
purchase in order to maintain and
improve their health through diet and
nutrition. On January 11, 2018, FDA
released its 2018 Strategic Policy
Roadmap (https://www.fda.gov/
AboutFDA/ReportsManualsForms/
Reports/ucm591993.htm), which
focuses, in part, on efforts to empower
consumers to make better and more
informed decisions about their diets and
health, foster the development of
healthier food options, and expand the
opportunities to use nutrition to reduce
morbidity and mortality due to chronic
disease. The roadmap highlights FDA’s
commitment to finding approaches to
advance policies that better achieve
these goals.
On March 29, 2018, FDA
Commissioner Dr. Scott Gottlieb, M.D.
announced a comprehensive, multi-year
FDA Nutrition Innovation Strategy
(hereinafter the ‘‘FDA Nutrition
Innovation Strategy’’) (to access the
speech, visit https://www.fda.gov/
NewsEvents/Speeches/ucm603057.htm).
The Nutrition Innovation Strategy seeks
to promote public health through
improved nutrition, encourage industry
innovation to create healthy products
that consumers seek, and address ways
for consumers to identify those
products. In implementing the Nutrition
Innovation Strategy, FDA is committed
to providing opportunities for public
input to help with these initiatives.
Early and active engagement from
stakeholders and the public will help to
inform FDA’s thinking and policy
actions.
II. Topics for Discussion at the Public
Meeting
FDA will host a 1-day meeting to
provide stakeholders and other
interested persons an opportunity to
have an in-depth discussion on various
aspects of the FDA Nutrition Innovation
Strategy and to provide input on ways
to modernize FDA’s approach to better
protect public health while removing
barriers to industry innovation. FDA
expects that the topics addressed at the
meeting will include the following (a
more detailed agenda will be made
available prior to the meeting):
• Considering using a standard icon
to denote the claim ‘‘healthy’’ on food
labels.
E:\FR\FM\27JNN1.SGM
27JNN1
30182
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices
• Creating a more efficient review
strategy for evaluating qualified health
claims on food labels.
• Discussing new or enhanced
labeling statements or claims that could
facilitate innovation to produce more
healthful foods and more healthful
consumer food choices.
• Modernizing the standards of
identity to provide more flexibility for
the development of healthier products,
while making sure consumers have
accurate information about these food
products.
• Providing opportunities to make
ingredient information more helpful to
consumers.
• FDA’s educational campaign for
consumers about the updated Nutrition
Facts Label.
We invite interested parties to provide
information on the above and other
topics related to the FDA Nutrition
Innovation Strategy.
III. Participating in the Public Meeting
Registration: To register for the public
meeting, please visit the following
website: https://www.fda.gov/Food/
NewsEvents/WorkshopsMeetings
Conferences/default.htm. Please provide
complete contact information for each
attendee, including name, title,
affiliation, address, email, and
telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public meeting must
register by July 19, 2018, midnight
Eastern Time. Early registration is
recommended because seating is
limited; therefore, FDA may limit the
number of participants from each
organization. Registrants will receive
confirmation when they have been
accepted.
If you need special accommodations
due to a disability, please contact
Juanita Yates (see FOR FURTHER
INFORMATION CONTACT) no later than July
12, 2018.
Requests for Oral Presentations:
During online registration you may
indicate if you wish to present during a
public comment session or participate
in a specific session, and which topic(s)
you wish to address. We will do our
best to accommodate requests to make
public comments and requests to
participate in the focused sessions.
Individuals and organizations with
common interests are urged to
consolidate or coordinate their
presentations, and request time for a
joint presentation, or submit requests for
designated representatives to participate
in the focused sessions. All requests to
make oral presentations must be
received by July 12, 2018, midnight
Eastern Time. We will determine the
amount of time allotted to each
presenter and the approximate time
each oral presentation is to begin, and
will select and notify participants by
July 16, 2018. Speakers will be limited
to making oral remarks; there will not be
an opportunity to display materials such
as slide shows, videos, or other media
during the meeting. No commercial or
promotional material will be permitted
to be presented or distributed at the
public meeting.
Streaming Webcast of the Public
Meeting: This public meeting will also
be webcast. Webcast participants are
asked to preregister at https://
www.fda.gov/Food/NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. It may
be viewed at the Dockets Management
Staff (see ADDRESSES). A link to the
transcript will also be available on the
internet at https://www.fda.gov/Food/
NewsEvents/WorkshopsMeetings
Conferences/default.htm.
Other Issues for Consideration: A
summary of key information on
participating in the meeting follows:
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING
Date
Preregister
Electronic address
Request to make
an oral presentation
July 19, 2018: Closing date for registration.
https://www.fda.gov/
Food/
NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
July 12, 2018 .........
Address
July 26, 2018 from
8:30 a.m. until
5:30 p.m. EDT.
Hilton Washington
DC/Rockville
Hotel, 1750
Rockville Pike,
Rockville, MD
20852.
Dated: June 22, 2018.
Leslie Kux,
Associate Commissioner for Policy.
seventh meeting of the Tick-Borne
Disease Working Group (Working
Group) on July 24, 2018, from 10:00 a.m.
to 4:00 p.m., Eastern Time. The seventh
meeting will be an on-line meeting held
via webcast. The Working Group will
review and vote on the content of the
five chapters that will be included in
the Working Group’s Report to
Congress.
[FR Doc. 2018–13831 Filed 6–26–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The Department of Health and
Human Services (HHS) announces the
SUMMARY:
VerDate Sep<11>2014
16:58 Jun 26, 2018
Jkt 244001
The on-line meeting will be held
on July 24, 2018, from 10:00 a.m. to 4:00
p.m. Eastern Time.
DATES:
This will be an on-line
meeting that is held via webcast.
Members of the public may attend the
meeting via webcast. Instructions for
attending this virtual meeting will be
posted prior to the meeting at: https://
ADDRESSES:
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
Special
accommodations
Submit either electronic or
written comments
July 12, 2018: clos- Submit Comments to: https://
ing date to rewww.regulations.gov, or
quest special acDockets Management Staff
commodations
(HFA–305), Food and Drug
due to a disability.
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/.
FOR FURTHER INFORMATION CONTACT:
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov or by phone at 202–795–7697.
SUPPLEMENTARY INFORMATION: The
Working Group invites public comment
on issues related to the Working Group’s
charge. Comments may be provided
over the phone during the meeting or in
writing. Persons who wish to provide
comments by phone should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before submitting a
request via email at tickbornedisease@
hhs.gov on or before July 19, 2018.
E:\FR\FM\27JNN1.SGM
27JNN1
]]>Agencies
[Federal Register Volume 83, Number 124 (Wednesday, June 27, 2018)]
[Notices]
[Pages 30180-30182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13831]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-2381]
The Food and Drug Administration's Comprehensive, Multi-Year
Nutrition Innovation Strategy; Public Meeting; Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
following public meeting entitled ``FDA's Comprehensive, Multi-Year
Nutrition Innovation Strategy.'' The purpose of the public meeting is
to give interested persons an opportunity to discuss FDA's nutrition
innovation strategy, including: A standard icon or symbol for the claim
``healthy''; a more efficient review strategy for evaluating qualified
health claims; statements or claims that could facilitate innovation to
promote healthful eating patterns; approaches for modernizing standards
of identity; possible changes that could make ingredient information
more consumer friendly; and FDA's educational campaign for consumers
about the updated Nutrition Facts Label that consumers will be seeing
in the marketplace.
DATES: The public meeting will be held on July 26, 2018, from 8:30 a.m.
until 5:30 p.m. Eastern Time. Submit either electronic or written
comments on this public meeting by August 27, 2018. See the
SUPPLEMENTARY INFORMATION section for registration date and
information.
ADDRESSES: The public meeting will be held at the Hilton Washington DC/
Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. For more
information on the hotel see https://www3.hilton.com/en/hotels/maryland/hilton-washington-dc-rockville-hotel-and-executive-meeting-ctr-IADMRHF/.
You may submit comments as follows. Please note that late, untimely
filed comments will not be considered.
[[Page 30181]]
Electronic comments must be submitted on or before August 27, 2018. The
https://www.regulations.gov electronic filing system will accept
comments until midnight Eastern Time at the end of August 27, 2018.
Comments received by mail/hand delivery/courier (for written/paper
submissions) will be considered timely if they are postmarked or the
delivery service acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2018-N-2381 for ``FDA's Comprehensive, Multi-Year Nutrition
Innovation Strategy.'' Received comments, those filed in a timely
manner (see ADDRESSES), will be placed in the docket and, except for
those submitted as ``Confidential Submissions,'' publicly viewable at
https://www.regulations.gov or at the Dockets Management Staff between
9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
For questions about registering for the meeting or to register by
phone: Melissa Schroeder, SIDEM, 1775 Eye St, NW, Suite 1150,
Washington, DC 20006, 240-393-4496, [email protected].
For general questions about the meeting or for special
accommodations due to a disability: Juanita Yates, Center for Food
Safety and Applied Nutrition (HFS-009), Food and Drug Administration,
5001 Campus Dr., College Park, MD 20740, 240-402-1731, email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background
FDA plays a critical role in promoting public health by, among
other things, ensuring that food labeling provides consumers with
reliable, evidence-based information so that they can make informed
choices about the foods they purchase in order to maintain and improve
their health through diet and nutrition. On January 11, 2018, FDA
released its 2018 Strategic Policy Roadmap (https://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm591993.htm), which focuses, in
part, on efforts to empower consumers to make better and more informed
decisions about their diets and health, foster the development of
healthier food options, and expand the opportunities to use nutrition
to reduce morbidity and mortality due to chronic disease. The roadmap
highlights FDA's commitment to finding approaches to advance policies
that better achieve these goals.
On March 29, 2018, FDA Commissioner Dr. Scott Gottlieb, M.D.
announced a comprehensive, multi-year FDA Nutrition Innovation Strategy
(hereinafter the ``FDA Nutrition Innovation Strategy'') (to access the
speech, visit https://www.fda.gov/NewsEvents/Speeches/ucm603057.htm).
The Nutrition Innovation Strategy seeks to promote public health
through improved nutrition, encourage industry innovation to create
healthy products that consumers seek, and address ways for consumers to
identify those products. In implementing the Nutrition Innovation
Strategy, FDA is committed to providing opportunities for public input
to help with these initiatives. Early and active engagement from
stakeholders and the public will help to inform FDA's thinking and
policy actions.
II. Topics for Discussion at the Public Meeting
FDA will host a 1-day meeting to provide stakeholders and other
interested persons an opportunity to have an in-depth discussion on
various aspects of the FDA Nutrition Innovation Strategy and to provide
input on ways to modernize FDA's approach to better protect public
health while removing barriers to industry innovation. FDA expects that
the topics addressed at the meeting will include the following (a more
detailed agenda will be made available prior to the meeting):
Considering using a standard icon to denote the claim
``healthy'' on food labels.
[[Page 30182]]
Creating a more efficient review strategy for evaluating
qualified health claims on food labels.
Discussing new or enhanced labeling statements or claims
that could facilitate innovation to produce more healthful foods and
more healthful consumer food choices.
Modernizing the standards of identity to provide more
flexibility for the development of healthier products, while making
sure consumers have accurate information about these food products.
Providing opportunities to make ingredient information
more helpful to consumers.
FDA's educational campaign for consumers about the updated
Nutrition Facts Label.
We invite interested parties to provide information on the above
and other topics related to the FDA Nutrition Innovation Strategy.
III. Participating in the Public Meeting
Registration: To register for the public meeting, please visit the
following website: https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm. Please provide complete
contact information for each attendee, including name, title,
affiliation, address, email, and telephone.
Registration is free and based on space availability, with priority
given to early registrants. Persons interested in attending this public
meeting must register by July 19, 2018, midnight Eastern Time. Early
registration is recommended because seating is limited; therefore, FDA
may limit the number of participants from each organization.
Registrants will receive confirmation when they have been accepted.
If you need special accommodations due to a disability, please
contact Juanita Yates (see FOR FURTHER INFORMATION CONTACT) no later
than July 12, 2018.
Requests for Oral Presentations: During online registration you may
indicate if you wish to present during a public comment session or
participate in a specific session, and which topic(s) you wish to
address. We will do our best to accommodate requests to make public
comments and requests to participate in the focused sessions.
Individuals and organizations with common interests are urged to
consolidate or coordinate their presentations, and request time for a
joint presentation, or submit requests for designated representatives
to participate in the focused sessions. All requests to make oral
presentations must be received by July 12, 2018, midnight Eastern Time.
We will determine the amount of time allotted to each presenter and the
approximate time each oral presentation is to begin, and will select
and notify participants by July 16, 2018. Speakers will be limited to
making oral remarks; there will not be an opportunity to display
materials such as slide shows, videos, or other media during the
meeting. No commercial or promotional material will be permitted to be
presented or distributed at the public meeting.
Streaming Webcast of the Public Meeting: This public meeting will
also be webcast. Webcast participants are asked to preregister at
https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm.
Transcripts: Please be advised that as soon as a transcript of the
public meeting is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff
(see ADDRESSES). A link to the transcript will also be available on the
internet at https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm.
Other Issues for Consideration: A summary of key information on
participating in the meeting follows:
Table 1--Information on Participation in the Meeting
--------------------------------------------------------------------------------------------------------------------------------------------------------
Submit either
Date Address Preregister Electronic address Request to make an Special electronic or
oral presentation accommodations written comments
--------------------------------------------------------------------------------------------------------------------------------------------------------
July 26, 2018 from 8:30 a.m. Hilton Washington July 19, 2018: https:// July 12, 2018..... July 12, 2018: Submit Comments
until 5:30 p.m. EDT. DC/Rockville Closing date for www.fda.gov/Food/ closing date to to: https://
Hotel, 1750 registration. NewsEvents/ request special www.regulations.g
Rockville Pike, WorkshopsMeetings accommodations ov, or Dockets
Rockville, MD Conferences/ due to a Management Staff
20852. default.htm. disability. (HFA-305), Food
and Drug
Administration,
5630 Fishers
Lane, Rm. 1061,
Rockville, MD
20852.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: June 22, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-13831 Filed 6-26-18; 8:45 am]
BILLING CODE 4164-01-P
